BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21295058)

  • 1. Blockade of CRF1 and CCK2 receptors attenuated the elevated anxiety-like behavior induced by immobilization stress.
    Wang H; Spiess J; Wong PT; Zhu YZ
    Pharmacol Biochem Behav; 2011 May; 98(3):362-8. PubMed ID: 21295058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
    Todorovic C; Radulovic J; Jahn O; Radulovic M; Sherrin T; Hippel C; Spiess J
    Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
    Cohen H; Kaplan Z; Matar MA; Buriakovsky I; Bourin M; Kotler M
    Depress Anxiety; 2004; 20(3):139-52. PubMed ID: 15487014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats.
    Wang H; Wong PT; Spiess J; Zhu YZ
    Neurosci Biobehav Rev; 2005; 29(8):1361-73. PubMed ID: 16120463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.
    Sherrin T; Blank T; Saravana R; Rayner M; Spiess J; Todorovic C
    Neuroscience; 2009 Aug; 162(1):14-22. PubMed ID: 19362130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced anxious behavior in mice lacking the CCK2 receptor gene.
    Horinouchi Y; Akiyoshi J; Nagata A; Matsushita H; Tsutsumi T; Isogawa K; Noda T; Nagayama H
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):157-61. PubMed ID: 15013032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
    Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
    J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
    Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
    Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
    J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain.
    Korosi A; Veening JG; Kozicz T; Henckens M; Dederen J; Groenink L; van der Gugten J; Olivier B; Roubos EW
    Brain Res; 2006 Feb; 1072(1):46-54. PubMed ID: 16423327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
    Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA).
    Miguel TT; Gomes KS; Nunes-de-Souza RL
    Horm Behav; 2014 Jul; 66(2):247-56. PubMed ID: 24848364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCK1 and 2 receptors are expressed in immortalized rat brain neuroblasts: intracellular signals after cholecystokinin stimulation.
    Langmesser S; Cerezo-Guisado MI; Lorenzo MJ; Garcia-Marin LJ; Bragado MJ
    J Cell Biochem; 2007 Mar; 100(4):851-64. PubMed ID: 17226751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
    Saito K; Kasai T; Nagura Y; Ito H; Kanazawa M; Fukudo S
    Gastroenterology; 2005 Nov; 129(5):1533-43. PubMed ID: 16285953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C; Samson P; Lalonde J; Richard D
    J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.
    Hodgson RA; Higgins GA; Guthrie DH; Lu SX; Pond AJ; Mullins DE; Guzzi MF; Parker EM; Varty GB
    Pharmacol Biochem Behav; 2007 Mar; 86(3):431-40. PubMed ID: 17291571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
    Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
    Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.